| Biological Information | |
|---|---|
| Background Information: | N-terminal FLAG-tagged, N-terminal 6His-tagged, recombinant, human CSNK1A1L, full length. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Predicted to be involved in negative regulation of canonical Wnt signaling pathway. May play a role in skeletal disorders and coronary artery calcification. |
| Target Class: | Kinase |
| Family: | CK1 (Casein kinase 1) |
| Sub Family: | Serine/threonine kinase |
| Accession Number: | NM_145203.6 |
| Target Name: | CSNK1A1L |
| Target Aliases: | CSNK1A1L, CK1a2, MGC33182, RP11-532O21.2, Casein kinase I isoform alpha-like CKI-alpha-like, Q8N752 |
| Target Species: | Human |
| Usage | |
| Product Type: | Enzymes |
| Application: | Drug Discovery & Development |
| Storage Conditions: | 12 months at -70°C |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Assay Information | |
| Assay Type: | Biochemical |
CSNK1A1L, active
10 µg of active CSNK1A1L. N-terminal FLAG-tagged, N-terminal 6His-tagged, recombinant, human CK1A1L, full length.
Datasheets
14-997_Datasheet
View Document